Previous close | 250.30 |
Open | N/A |
Bid | 212.00 |
Ask | 222.00 |
Strike | 1,160.00 |
Expiry date | 2025-06-20 |
Day's range | 250.30 - 250.30 |
Contract range | N/A |
Volume | |
Open interest | 1 |
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.